Thorac Cardiovasc Surg 2020; 68(04): 282-290
DOI: 10.1055/s-0038-1677511
Original Cardiovascular
Georg Thieme Verlag KG Stuttgart · New York

Serum Neuron-Specific Enolase Level as Predictor of Neurologic Outcome after Aortic Surgery

Fumiaki Kimura
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Takayuki Kadohama
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Hiroto Kitahara
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Hayato Ise
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Sentaro Nakanishi
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Nobuyuki Akasaka
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
,
Hiroyuki Kamiya
1   Department of Cardiac Surgery, Asahikawa Medical University, Asahikawa, Japan
› Author Affiliations
Funding The study received no funding from any source.
Further Information

Publication History

24 October 2018

07 December 2018

Publication Date:
22 January 2019 (online)

Abstract

Background This study aimed to evaluate the significance of serum neuron-specific enolase (NSE) level as a predictor of neurologic injury in thoracic aortic surgery.

Methods We neurologically assessed 60 consecutive patients who underwent thoracic aortic surgery for thoracic aortic aneurysm (n = 26) and aortic dissection (n = 34). Using moderate hypothermic circulatory arrest with antegrade cerebral perfusion, total arch replacement and hemiarch replacement were performed in 37 and 23 patients, respectively. Serum NSE levels in venous blood samples drawn before surgery and at 1 day after surgery were measured. Severity of neurologic injury was categorized as either uncomplicated (n = 48), temporary neurologic dysfunction (TND, n = 5), or permanent neurologic dysfunction (PND, n = 7). The extent of stroke was estimated on computed tomography or magnetic resonance imaging.

Results The NSE level significantly differed among the three groups (PND > TND > uncomplicated) on the first postoperative day. Receiver-operating characteristic curve analysis showed that the cutoff value of NSE level was 34.14 ng/mL for neurologic injury (sensitivity, 0.769; specificity, 0.851) and 43.56 ng/mL for PND (sensitivity, 1.000; specificity, 0.963). The NSE level significantly correlated with the extent of stroke (r = 0.61, p < 0.001).

Conclusion Serum NSE level is a significant predictor of adverse neurologic outcomes and extent of stroke after thoracic aortic surgery.

 
  • References

  • 1 Roine RO, Somer H, Kaste M, Viinikka L, Karonen SL. Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis. Arch Neurol 1989; 46 (07) 753-756
  • 2 Ishiguro Y, Kato K, Shimizu A, Ito T, Nagaya M. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma. Clin Chim Acta 1982; 121 (02) 173-180
  • 3 Carney DN, Marangos PJ, Ihde DC. , et al. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1982; 1 (8272): 583-585
  • 4 Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases. J Neurol Sci 1983; 60 (03) 443-451
  • 5 Schaarschmidt H, Prange HW, Reiber H. Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases. Stroke 1994; 25 (03) 558-565
  • 6 Kärkelä J, Bock E, Kaukinen S. CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man. J Neurol Sci 1993; 116 (01) 100-109
  • 7 Hårdemark HG, Ericsson N, Kotwica Z. , et al. S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J Neurosurg 1989; 71 (5 Pt 1): 727-731
  • 8 Kothari RU, Brott T, Broderick JP. , et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996; 27 (08) 1304-1305
  • 9 Pedraza S, Puig J, Blasco G. , et al. Reliability of the ABC/2 method in determining acute infarct volume. J Neuroimaging 2012; 22 (02) 155-159
  • 10 Seco M, Edelman JJ, Wilson MK, Bannon PG, Vallely MP. Serum biomarkers of neurologic injury in cardiac operations. Ann Thorac Surg 2012; 94 (03) 1026-1033
  • 11 Sims JR, Gharai LR, Schaefer PW. , et al. ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009; 72 (24) 2104-2110
  • 12 Ergin MA, Galla JD, Lansman L, Quintana C, Bodian C, Griepp RB. Hypothermic circulatory arrest in operations on the thoracic aorta. Determinants of operative mortality and neurologic outcome. J Thorac Cardiovasc Surg 1994; 107 (03) 788-797 , discussion 797–799
  • 13 Selim M. Perioperative stroke. N Engl J Med 2007; 356 (07) 706-713
  • 14 Singh P, Yan J, Hull R. , et al. Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke. J Neurol Sci 2011; 304 (1-2): 117-121
  • 15 Wunderlich MT, Wallesch CW, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006; 13 (10) 1118-1123
  • 16 Shiiya N, Kunihara T, Miyatake T, Matsuzaki K, Yasuda K. Tau protein in the cerebrospinal fluid is a marker of brain injury after aortic surgery. Ann Thorac Surg 2004; 77 (06) 2034-2038
  • 17 Fletcher L, Rider CC, Taylor CB. Enolase isoenzymes. III. Chromatographic and immunological characteristics of rat brain enolase. Biochim Biophys Acta 1976; 452 (01) 245-252
  • 18 Rider CC, Taylor CB. Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties. Biochim Biophys Acta 1974; 365 (01) 285-300
  • 19 Marangos PJ, Schmechel DE. Neuron specific enolase, a clinically useful marker for neurons and neuroendocrine cells. Annu Rev Neurosci 1987; 10: 269-295
  • 20 Georgiadis D, Berger A, Kowatschev E. , et al. Predictive value of S-100beta and neuron-specific enolase serum levels for adverse neurologic outcome after cardiac surgery. J Thorac Cardiovasc Surg 2000; 119 (01) 138-147
  • 21 Hårdemark HG, Persson L, Bolander HG, Hillered L, Olsson Y, Påhlman S. Neuron-specific enolase is a marker of cerebral ischemia and infarct size in rat cerebrospinal fluid. Stroke 1988; 19 (09) 1140-1144
  • 22 Jönsson H, Johnsson P, Birch-Iensen M, Alling C, Westaby S, Blomquist S. S100B as a predictor of size and outcome of stroke after cardiac surgery. Ann Thorac Surg 2001; 71 (05) 1433-1437
  • 23 Vercaemst L. Hemolysis in cardiac surgery patients undergoing cardiopulmonary bypass: a review in search of a treatment algorithm. J Extra Corpor Technol 2008; 40 (04) 257-267
  • 24 Marangos PJ, Campbell IC, Schmechel DE, Murphy DL, Goodwin FK. Blood platelets contain a neuron-specific enolase subunit. J Neurochem 1980; 34 (05) 1254-1258
  • 25 Beaudeux JL, Léger P, Dequen L, Gandjbakhch I, Coriat P, Foglietti MJ. Influence of hemolysis on the measurement of S-100beta protein and neuron-specific enolase plasma concentrations during coronary artery bypass grafting. Clin Chem 2000; 46 (07) 989-990
  • 26 Ramont L, Thoannes H, Volondat A, Chastang F, Millet MC, Maquart FX. Effects of hemolysis and storage condition on neuron-specific enolase (NSE) in cerebrospinal fluid and serum: implications in clinical practice. Clin Chem Lab Med 2005; 43 (11) 1215-1217